Global HIV-AIDS Testing Market 2014-2018
出 版 商：Infiniti Research
出版日期：2014/04/25
頁 數：99頁
文件格式：PDF
價 格：
USD 2,500 (Single-User License)
USD 3,500 (Multi-User License)
USD 10,000 (Global-User License)
USD 3,500 (Multi-User License)
USD 10,000 (Global-User License)
About HIV-AIDS Testing
AIDS is a condition caused due to the gradual weakening of the human body's immune system. This weakening is caused by a virus called HIV, which attacks the body's white blood cells, specifically a subset called CD4 or helper T cells. AIDS/HIV testing devices are medical devices that are used to determine the presence of HIV in human blood. A number of testing devices are available including the HIV antibody test, the Antigen (P24) test, and the PCR test.
TechNavio's analysts forecast the Global HIV-AIDS Testing market will grow at a CAGR of 5.43 percent over the period 2013-2018.
Covered in this Report
The Global HIV-AIDS Testing market can be divided into three segments: HIV-AIDS Screening Assays, HIV-AIDS Confirmatory Assays, and HIV-AIDS Monitoring Assays.
TechNavio's report, the Global HIV-AIDS Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global HIV-AIDS Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
‧ Americas
‧ EMEA
‧ APAC
Key Vendors
‧ Abbott Laboratories
‧ Bio-Rad Laboratories Inc.
‧ Hologic Inc.
‧ Ortho-Clinical Diagnostics Inc.
‧ Roche Diagnostics
‧ Siemens Healthcare Diagnostics Inc.
Other Prominent Vendors
‧ bioMerieux SA
‧ Calypte Biomedical Corp.
‧ Fujirebio Diagnostics Inc.
‧ Medical Services International Inc.
‧ MedMira Laboratories Inc.
‧ OraSure Technologies Inc.
‧ Quest Diagnostics Inc.
‧ Trinity Biotech plc
Market Driver
‧ Increase in Number of People Prone to HIV/AIDS.
‧ For a full, detailed list, view our report.
Market Challenge
‧ Intense Competition among Vendors.
‧ For a full, detailed list, view our report.
Market Trend
‧ Adoption of AIDS/HIV Workplace Policies by Companies.
‧ For a full, detailed list, view our report.
Key Questions Answered in this Report
‧ What will the market size be in 2018 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
AIDS is a condition caused due to the gradual weakening of the human body's immune system. This weakening is caused by a virus called HIV, which attacks the body's white blood cells, specifically a subset called CD4 or helper T cells. AIDS/HIV testing devices are medical devices that are used to determine the presence of HIV in human blood. A number of testing devices are available including the HIV antibody test, the Antigen (P24) test, and the PCR test.
TechNavio's analysts forecast the Global HIV-AIDS Testing market will grow at a CAGR of 5.43 percent over the period 2013-2018.
Covered in this Report
The Global HIV-AIDS Testing market can be divided into three segments: HIV-AIDS Screening Assays, HIV-AIDS Confirmatory Assays, and HIV-AIDS Monitoring Assays.
TechNavio's report, the Global HIV-AIDS Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global HIV-AIDS Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
‧ Americas
‧ EMEA
‧ APAC
Key Vendors
‧ Abbott Laboratories
‧ Bio-Rad Laboratories Inc.
‧ Hologic Inc.
‧ Ortho-Clinical Diagnostics Inc.
‧ Roche Diagnostics
‧ Siemens Healthcare Diagnostics Inc.
Other Prominent Vendors
‧ bioMerieux SA
‧ Calypte Biomedical Corp.
‧ Fujirebio Diagnostics Inc.
‧ Medical Services International Inc.
‧ MedMira Laboratories Inc.
‧ OraSure Technologies Inc.
‧ Quest Diagnostics Inc.
‧ Trinity Biotech plc
Market Driver
‧ Increase in Number of People Prone to HIV/AIDS.
‧ For a full, detailed list, view our report.
Market Challenge
‧ Intense Competition among Vendors.
‧ For a full, detailed list, view our report.
Market Trend
‧ Adoption of AIDS/HIV Workplace Policies by Companies.
‧ For a full, detailed list, view our report.
Key Questions Answered in this Report
‧ What will the market size be in 2018 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. HIV and AIDS Overview
05.1.1 Types of HIV
06. Introduction
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Category
08.1 Global HIV-AIDS Testing Market by Category
09. Types of HIV Tests
09.1.1 Antibody Tests
09.1.2 Antigen Tests
09.1.3 PCR Tests
10. Geographical Segmentation
10.1 Global HIV-AIDS Testing Market by Geographical Segmentation
11. Top 20 Countries with HIV Infected Population
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Abbott Laboratories
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Business Segmentation
20.1.4 Business Strategy
20.1.5 Revenue Segmentation
20.1.6 Revenue Comparison 2012 and 2011
20.1.7 Geographical Segmentation
20.1.8 Key Information
20.1.9 SWOT Analysis
20.1.10 Strengths
20.1.11 Weakness
20.1.12 Opportunities
20.1.13 Threats
20.2 Bio-Rad Laboratories Inc.
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Segmentation
20.2.4 Business Strategy
20.2.5 Revenue Segmentation of Bio-Rad Laboratories Inc.
20.2.6 Revenue Comparison FY2012 and FY2011
20.2.7 Bio-Rad Laboratories Inc. by Geographical Segmentation
20.2.8 Key Information
20.2.9 SWOT Analysis
20.2.10 Strengths
20.2.11 Weakness
20.2.12 Opportunities
20.2.13 Threats
20.3 Hologic Inc.
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Business Segmentation
20.3.4 Business Strategy
20.3.5 Revenue Segmentation
20.3.6 Revenue Comparison FY2012 and FY2013
20.3.7 Geographical Segmentation
20.3.8 Key Information
20.3.9 SWOT Analysis
20.3.10 Strengths
20.3.11 Weaknesses
20.3.12 Opportunities
20.3.13 Threats
20.4 Ortho-Clinical Diagnostics Inc.
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Key Information
20.4.4 SWOT Analysis
20.4.5 Strengths
20.4.6 Weakness
20.4.7 Opportunities
20.4.8 Threats
20.5 Roche Diagnostics
20.5.1 Key Facts
20.5.2 Business Description
20.5.3 Business Segmentation
20.5.4 Revenue Segmentation
20.5.5 Geographical Segmentation
20.5.6 Business Strategy
20.5.7 Key Information
20.5.8 SWOT Analysis
20.5.9 Strengths
20.5.10 Weaknesses
20.5.11 Opportunities
20.5.12 Threats
20.6 Siemens Healthcare Diagnostics Inc.
20.6.1 Key Facts
20.6.2 Business Overview
20.6.3 Key Information
20.6.4 Business Strategy
20.6.5 SWOT Analysis
20.6.6 Strengths
20.6.7 Weaknesses
20.6.8 Opportunities
20.6.9 Threats
21. Other Reports in this Series
Exhibit 1: Market Research Methodology
Exhibit 2: Global HIV-AIDS Testing Market Overview
Exhibit 3: Global HIV-AIDS Testing market 2013-2018 (US$ billion)
Exhibit 4: Global HIV-AIDS Testing Market Segmentation by Category
Exhibit 5: Global HIV-AIDS Testing Market Segmentation by Category 2013
Exhibit 6: Types of HIV Tests
Exhibit 7: Global HIV-AIDS Testing Market by Geographical Segmentation 2013
Exhibit 8: Top 20 HIV Infected Countries with HIV Infected Population 2012
Exhibit 9: Business Segmentation of Abbott Laboratories
Exhibit 10: Revenue Segmentation of Abbott Laboratories 2012
Exhibit 11: Revenue Comparison 2012 and 2011 (US$ million)
Exhibit 12: Abbott Laboratories by Geographical Segmentation 2012
Exhibit 13: Business Segmentation of Bio-Rad Laboratories Inc.
Exhibit 14: Revenue Segmentation of Bio-Rad Laboratories Inc. FY2012
Exhibit 15: Revenue Comparison 2012 and 2011(US$ million)
Exhibit 16: Bio-Rad Laboratories Inc. by Geographical Segmentation 2012
Exhibit 17: Business Segmentation of Hologic Inc.
Exhibit 18: Revenue Segmentation of Hologic Inc. 2013
Exhibit 19: Revenue Comparison FY2012 and FY2013 (US$ million)
Exhibit 20: Hologic Inc. by Geographical Segmentation 2013
Exhibit 21: Business Segmentation of Roche Diagnostics
Exhibit 22: Revenue Segmentation of Roche Diagnostics FY2013
Exhibit 23: Roche Diagnostics by Geographical Segmentation FY2013
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. HIV and AIDS Overview
05.1.1 Types of HIV
06. Introduction
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Category
08.1 Global HIV-AIDS Testing Market by Category
09. Types of HIV Tests
09.1.1 Antibody Tests
09.1.2 Antigen Tests
09.1.3 PCR Tests
10. Geographical Segmentation
10.1 Global HIV-AIDS Testing Market by Geographical Segmentation
11. Top 20 Countries with HIV Infected Population
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Abbott Laboratories
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Business Segmentation
20.1.4 Business Strategy
20.1.5 Revenue Segmentation
20.1.6 Revenue Comparison 2012 and 2011
20.1.7 Geographical Segmentation
20.1.8 Key Information
20.1.9 SWOT Analysis
20.1.10 Strengths
20.1.11 Weakness
20.1.12 Opportunities
20.1.13 Threats
20.2 Bio-Rad Laboratories Inc.
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Segmentation
20.2.4 Business Strategy
20.2.5 Revenue Segmentation of Bio-Rad Laboratories Inc.
20.2.6 Revenue Comparison FY2012 and FY2011
20.2.7 Bio-Rad Laboratories Inc. by Geographical Segmentation
20.2.8 Key Information
20.2.9 SWOT Analysis
20.2.10 Strengths
20.2.11 Weakness
20.2.12 Opportunities
20.2.13 Threats
20.3 Hologic Inc.
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Business Segmentation
20.3.4 Business Strategy
20.3.5 Revenue Segmentation
20.3.6 Revenue Comparison FY2012 and FY2013
20.3.7 Geographical Segmentation
20.3.8 Key Information
20.3.9 SWOT Analysis
20.3.10 Strengths
20.3.11 Weaknesses
20.3.12 Opportunities
20.3.13 Threats
20.4 Ortho-Clinical Diagnostics Inc.
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Key Information
20.4.4 SWOT Analysis
20.4.5 Strengths
20.4.6 Weakness
20.4.7 Opportunities
20.4.8 Threats
20.5 Roche Diagnostics
20.5.1 Key Facts
20.5.2 Business Description
20.5.3 Business Segmentation
20.5.4 Revenue Segmentation
20.5.5 Geographical Segmentation
20.5.6 Business Strategy
20.5.7 Key Information
20.5.8 SWOT Analysis
20.5.9 Strengths
20.5.10 Weaknesses
20.5.11 Opportunities
20.5.12 Threats
20.6 Siemens Healthcare Diagnostics Inc.
20.6.1 Key Facts
20.6.2 Business Overview
20.6.3 Key Information
20.6.4 Business Strategy
20.6.5 SWOT Analysis
20.6.6 Strengths
20.6.7 Weaknesses
20.6.8 Opportunities
20.6.9 Threats
21. Other Reports in this Series
Exhibit 1: Market Research Methodology
Exhibit 2: Global HIV-AIDS Testing Market Overview
Exhibit 3: Global HIV-AIDS Testing market 2013-2018 (US$ billion)
Exhibit 4: Global HIV-AIDS Testing Market Segmentation by Category
Exhibit 5: Global HIV-AIDS Testing Market Segmentation by Category 2013
Exhibit 6: Types of HIV Tests
Exhibit 7: Global HIV-AIDS Testing Market by Geographical Segmentation 2013
Exhibit 8: Top 20 HIV Infected Countries with HIV Infected Population 2012
Exhibit 9: Business Segmentation of Abbott Laboratories
Exhibit 10: Revenue Segmentation of Abbott Laboratories 2012
Exhibit 11: Revenue Comparison 2012 and 2011 (US$ million)
Exhibit 12: Abbott Laboratories by Geographical Segmentation 2012
Exhibit 13: Business Segmentation of Bio-Rad Laboratories Inc.
Exhibit 14: Revenue Segmentation of Bio-Rad Laboratories Inc. FY2012
Exhibit 15: Revenue Comparison 2012 and 2011(US$ million)
Exhibit 16: Bio-Rad Laboratories Inc. by Geographical Segmentation 2012
Exhibit 17: Business Segmentation of Hologic Inc.
Exhibit 18: Revenue Segmentation of Hologic Inc. 2013
Exhibit 19: Revenue Comparison FY2012 and FY2013 (US$ million)
Exhibit 20: Hologic Inc. by Geographical Segmentation 2013
Exhibit 21: Business Segmentation of Roche Diagnostics
Exhibit 22: Revenue Segmentation of Roche Diagnostics FY2013
Exhibit 23: Roche Diagnostics by Geographical Segmentation FY2013
